CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms | ||
| dc.conicet.organizacion | Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas | |
| dc.conicet.organizacion | Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas | |
| dc.conicet.organizacion | Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas | |
| dc.conicet.organizacion | Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas | |
| dc.contributor.author | Ojeda, Mara Jorgelina | |
| dc.contributor.author | Bragós, Irma Margarita | |
| dc.contributor.author | Calvo, Karina Lucrecia | |
| dc.contributor.author | Williams, Gladis Marcela | |
| dc.contributor.author | Carbonell, María Magdalena | |
| dc.contributor.author | Pratti, Arianna Flavia | |
| dc.date.issued | 2018-04 | |
| dc.description.abstract | Objectives: To establish the frequency of JAK2, MPL and CALR mutations in Argentinean patients with BCR-ABL1-negative myeloproliferative neoplasms (MPN) and to compare their clinical and haematological features. Methods: Mutations of JAK2V617F, JAK2 exon 12, MPL W515L/K and CALR were analysed in 439 Argentinean patients with BCR-ABL1-negative MPN, including 176 polycythemia vera (PV), 214 essential thrombocythemia (ET) and 49 primary myelofibrosis (PMF). Results: In 94.9% of PV, 85.5% ET and 85.2% PMF, we found mutations in JAK2, MPL or CALR. 74.9% carried JAK2V617F, 12.3% CALR mutations, 2.1% MPL mutations and 10.7% were triple negative. In ET, nine types of CALR mutations were identified, four of which were novel. PMF patients were limited to types 1 and 2, type 2 being more frequent. Discussion: In ET, patients with CALR mutation were younger and had higher platelet counts than those with JAK2V617F and triple negative. In addition, JAK2V617F patients had high leucocyte and haemoglobin values compared with CALR-mutated and triple-negative patients. In PMF, patients with mutant CALR were associated with higher platelet counts. Conclusion: Our study underscores the importance of JAK2, MPL and CALR genotyping for accurate diagnosis of patients with BCR-ABL1-negative MPN. | es |
| dc.description.fil | Fil: Ojeda, Mara Jorgelina. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Bragós, Irma Margarita. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina | |
| dc.description.fil | Fil: Calvo, Karina Lucrecia. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Williams, Gladis Marcela. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina | |
| dc.description.fil | Fil: Carbonell, María Magdalena. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina | |
| dc.description.fil | Fil: Pratti, Arianna Flavia. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Ojeda, Mara Jorgelina; Bragós, Irma Margarita; Calvo, Karina Lucrecia; Williams, Gladis Marcela; Carbonell, María Magdalena; et al.; CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms; Taylor & Francis; Hematology; 23; 4; 4-2018; 208-211 | es |
| dc.identifier.eissn | 1607-8454 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1024-5332 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/87332 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 4 | es |
| dc.journal.pagination | 208-211 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Hematology | es |
| dc.journal.volume | 23 | es |
| dc.language.iso | eng | es |
| dc.publisher | Taylor & Francis | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1080/10245332.2017.1385891 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1080/10245332.2017.1385891 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/2.5/ar/ | * |
| dc.subject | CALRETICULIN | es |
| dc.subject | ESSENTIAL THROMBOCYTHEMIA | es |
| dc.subject | JAK2V617F;MPL | es |
| dc.subject | MYELOPROLIFERATIVE NEOPLASMS | es |
| dc.subject | POLYCYTHEMIA VERA | es |
| dc.subject | PRIMARY MYELOFIBROSIS | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.166dd28e-e1e3-4848-9e04-1a6adca21328_A.pdf
- Tamaño:
- 793.71 KB
- Formato:
- Adobe Portable Document Format